Skip to main content

Published locations for FDA’s Dapagliflozin Review to Focus on Hepatic Effects, Cancer Risks

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA’s Dapagliflozin Review to Focus on Hepatic Effects, Cancer Risks

User login

  • Reset your password
  • /content/fdas-dapagliflozin-review-focus-hepatic-effects-cancer-risks
  • /familypracticenews/article/36639/endocrinology/fdas-dapagliflozin-review-focus-hepatic-effects
  • /internalmedicinenews/article/36639/endocrinology/fdas-dapagliflozin-review-focus-hepatic-effects
  • /internalmedicine/article/36639/endocrinology/fdas-dapagliflozin-review-focus-hepatic-effects-cancer
  • /familymedicine/article/36639/endocrinology/fdas-dapagliflozin-review-focus-hepatic-effects-cancer